drugset
Drugs / RUTI
last change Oct 2025 re-read 3 minutes ago

RUTI

Vaccine

Developed for
latent tuberculosis infection
Investigated by
Archivel Farma S.L. · Parexel

Trials 1

today NCT01136161 · Ph 2
201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01136161 Jun 2010 → May 2011 latent tuberculosis infection Archivel Farma S.L. Completed No outcome recorded

Press releases naming this drug 10 releases

DateIssuerRelease
2025-10-20 Archivel Farma S.L. RUTI® in combination with BCG Therapy Show Encouraging Outcomes in Bladder Cancer archivelfarma.com ↗
2023-11-09 Archivel Farma S.L. Significant efficacy of RUTI® vaccine in a non-clinical study of active tuberculosis archivelfarma.com ↗
2022-09-30 Archivel Farma S.L. A new clinical trial, CONSTAN-ARG, will test the effectiveness of the #RUTI® vaccine archivelfarma.com ↗
2021-10-22 Archivel Farma S.L. The STriTuVaD Consortium is proud to announce the recruitment of the First Patient in the STriTuVaD Clinical Trial of RUTI® Vaccine for Tuberculosis (TB) archivelfarma.com ↗
2020-04-08 Archivel Farma S.L. Archivel Farma’s RUTI ® vaccine to start a clinical trial to increase the immunity of healthcare professionals exposed to the risk of COVID-19 archivelfarma.com ↗
2018-03-20 Archivel Farma S.L. Archivel Farma and Laboratorios Silanes to collaborate in the development of the anti-tuberculosis vaccine RUTI ® in México archivelfarma.com ↗
2017-10-19 Archivel Farma S.L. The RUTI ® vaccine for the treatment of tuberculosis, presented to the WHO experts archivelfarma.com ↗
2014-03-28 Archivel Farma S.L. Archivel Farma looks for partners to start the last stage of development of RUTI ® vaccine archivelfarma.com ↗
2014-02-28 Archivel Farma S.L. Results of RUTI ® ‘s Phase II clinical trial, published in Plos One archivelfarma.com ↗
2012-01-15 Archivel Farma S.L. Archivel secures funding to bring the anti-tuberculosis therapeutic vaccine RUTI® to market archivelfarma.com ↗

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as RUTI ClinicalTrials.gov intervention name — accepted as the source's own label NCT01136161 ↗
Modality Vaccine “novel antituberculous vaccine RUTI” NCT01136161 ↗
Route Subcutaneous “given subcutaneously twice, on days 28 and 56.” NCT01136161 ↗